Clinical Trial Update: A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating a treatment for moderate to severe knee pain due to osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED